Plasmonic nanomaterials bearing targeting ligands are of great interest for surface‐enhanced Raman scattering (SERS)‐based bioimaging applications. However, the practical utility of SERS‐based imaging strategies is hindered by the lack of a straightforward method to synthesize highly sensitive SERS‐active nanostructures with high yield and efficiency. In this work, leveraging DNA origami principles, the first‐in‐class design of a SERS‐based plasmonically coupled nanoprobe for targeted cancer imaging (SPECTRA) is reported. The nanoprobe harnesses a cancer cell targeting DNA aptamer sequence and vibrational tag with stretching frequency in the cell‐silent Raman window. Through the integration of aptamer sequence specific for DU145 cells, the unique capabilities of SPECTRA for targeted imaging of DU145 cells are shown. The results demonstrate that the scalability, cost‐effectiveness, and reproducibility of this method of fabrication of SERS nanoprobes can serve as a versatile platform for creating nanoprobes with broad applications in the fields of cancer biology and biomedical imaging.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: